Hadi Valizadeh
Overview
Explore the profile of Hadi Valizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
1851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahednezhad F, Allahyari S, Sarfraz M, Zakeri-Milani P, Feyzizadeh M, Valizadeh H
Expert Opin Drug Deliv
. 2024 Sep;
21(9):1363-1384.
PMID: 39282895
Introduction: Targeted liposomal systems for cancer intention have been recognized as a specific and robust approach compared to conventional liposomal delivery systems. Cancer cells have a unique microenvironment with special...
2.
Khaleseh F, Barzegar-Jalali M, Zakeri-Milani P, Karami Z, Saghatchi Zanjani M, Valizadeh H
Iran J Basic Med Sci
. 2024 May;
27(7):857-867.
PMID: 38800017
Objectives: Lipid-based drug delivery systems (DDS) can improve the pharmacokinetic (PK) parameters of some drugs. Especially those with a high volume of distribution (Vd) leading to off-target accumulation and toxicity....
3.
Kiaie S, Zangi A, Sheibani M, Hemmati S, Baradaran B, Valizadeh H
Purinergic Signal
. 2024 Mar;
20(5):533-546.
PMID: 38436880
The development of ionizable lipid (IL) was necessary to enable the effective formulation of small interfering RNA (siRNA) to inhibit P2X7 receptors (P2X7R), a key player in tumor proliferation, apoptosis,...
4.
Mostafaei F, Hemmati S, Valizadeh H, Mahmoudian M, Sarfraz M, Abdi M, et al.
Int J Pharm
. 2023 Nov;
649:123635.
PMID: 38000649
Asialoglycoprotein receptors (ASGPRs) are highly expressed on hepatocytes and have been used for liver-targeted delivery and hepatocellular carcinoma (HCC) therapy. However, targeted delivery of bortezomib (BTZ) to HCC has not...
5.
Mostafaei F, Mahdinloo S, Valizadeh H, Hemmati S, Abdi M, Sarfraz M, et al.
Nanomedicine (Lond)
. 2023 Nov;
18(25):1855-1873.
PMID: 37991168
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, typically diagnosed in advanced stages. Chemotherapy is necessary for treating advanced liver cancer; however, several challenges affect its...
6.
Kiaie S, Hatami Z, Nasr M, Pazooki P, Hemmati S, Baradaran B, et al.
Purinergic Signal
. 2023 Oct;
20(4):321-343.
PMID: 37843749
Nucleosides and purine nucleotides serve as transmitter and modulator agents that extend their functions beyond the cell. In this context, purinergic signaling plays a crucial role in regulating energy homeostasis...
7.
Valizadeh H, Mahdinloo S, Zakeri N, Sarfraz M, Nezafat S, Zakeri-Milani P
Adv Pharm Bull
. 2023 Aug;
13(3):532-538.
PMID: 37646059
Purpose: Poor aqueous solubility hampers the development of several compounds as pharmacological agents. Hence, preparing novel formulations with augmented absorption is a challenge in pharmaceutical industries. In this paper, we...
8.
Seify R, Zahednezhad F, Zakeri-Milani P, Valizadeh H
Drug Dev Ind Pharm
. 2023 May;
49(5):367-376.
PMID: 37249553
Objective: This study was intended to explore and evaluate the appropriate methods for preparation of Amphotericin B (AmB) liposomes with acceptable characteristics. Significance: This project provides pre-formulations for industrial manufacturing...
9.
Khazaei Monfared Y, Rubin Pedrazzo A, Mahmoudian M, Caldera F, Zakeri-Milani P, Valizadeh H, et al.
Colloids Surf B Biointerfaces
. 2022 Dec;
222:113101.
PMID: 36529037
Many nutraceuticals present problems due to their poor water solubility or stability, which prevents the final bioactivity achievement. For that reason, the oral administration of KYNA complexed with HPβ-CD and...
10.
Gholikhani T, Kumar S, Valizadeh H, Mahdinloo S, Adibkia K, Zakeri-Milani P, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430951
Aptamers are synthetic single-stranded oligonucleotides (such as RNA and DNA) evolved in vitro using Systematic Evolution of Ligands through Exponential enrichment (SELEX) techniques. Aptamers are evolved to have high affinity...